Discover
NGNE
Neurogene Inc.
33.88
2 x 23.89
2 x 40.42
bid
ask
+
2.43
7.73%
2 @ 04:00 PM
34.17 +0.29 (0.86%)
| Ytd | 64.47% | |
| 1y | 76.55% |
31.43
day range
34.35
15.93
52 week range
37.27
| Open | 31.89 | Prev Close | 31.45 | Low | 31.43 | High | 34.35 | Mkt Cap | 535.37M |
| Vol | 677.22K | Avg Vol | 180.08K | EPS | -4.55 | P/E | N/A | Forward P/E | -4.85 |
| Beta | N/A | Short Ratio | 7.15 | Inst. Own | 110.72% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 28.97 | 200-d Avg | 23.63 | 1yr Est | 52.80 |
| Income Statement | |||
| Operating Expenses | 33.35M | ||
| Research and Development Expense | 25.15M | ||
| Selling, General and Administrative Expense | 8.20M | ||
| Operating Income | -33.35M | ||
| Net Income | -30.93M | ||
| Net Income Common Stock | -30.93M | ||
| Net Income Common Stock (USD) | -30.93M | ||
| Consolidated Income | -30.93M | ||
| Earnings per Basic Share | -1.39 | ||
| Earnings per Basic Share (USD) | -1.39 | ||
| Earnings per Diluted Share | -1.39 | ||
| Earning Before Interest & Taxes (EBIT) | -30.93M | ||
| Earning Before Interest & Taxes (USD) | -30.93M | ||
| Weighted Average Shares | 22.31M | ||
| Weighted Average Shares Diluted | 22.31M | ||
| Balance Sheet | |||
| Cash and Equivalents | 124.50M | ||
| Cash and Equivalents (USD) | 124.50M | ||
| Investments | 119.02M | ||
| Investments Current | 119.02M | ||
| Current Assets | 246.75M | ||
| Property, Plant & Equipment Net | 14.98M | ||
| Total Assets | 263.14M | ||
| Debt Current | 3.05M | ||
| Total Debt | 9.13M | ||
| Current Liabilities | 18.87M | ||
| Debt Non-Current | 6.08M | ||
| Total Liabilities | 25.36M | ||
| Accumulated Retained Earnings (Deficit) | -383.58M | ||
| Shareholders Equity | 237.78M | ||
| Shareholders Equity (USD) | 237.78M | ||
| Assets Non-Current | 16.39M | ||
| Total Debt (USD) | 9.13M | ||
| Liabilities Non-Current | 6.49M | ||
| Trade and Non-Trade Payables | 4.68M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.04M | ||
| Net Cash Flow from Financing | 195.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 20.32M | ||
| Capital Expenditure | -281.00K | ||
| Issuance (Purchase) of Equity Shares | 201.00K | ||
| Issuance (Repayment) of Debt Securities | -6.00K | ||
| Net Cash Flow from Investing | 46.24M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 46.52M | ||
| Net Cash Flow from Operations | -26.12M | ||
| Share Based Compensation | 3.63M | ||